Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Oramed Pharmaceuticals (ORMP) Tax Rate (2016 - 2026)

Oramed Pharmaceuticals filings provide 5 years of Tax Rate readings, the most recent being 81.12% for Q4 2025.

  • Quarterly Tax Rate fell 7686.0% to 81.12% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 4.74% through Dec 2025, up 2474.0% year-over-year, with the annual reading at 4.74% for FY2025, 2474.0% up from the prior year.
  • Tax Rate hit 81.12% in Q4 2025 for Oramed Pharmaceuticals, down from 18.61% in the prior quarter.
  • Across five years, Tax Rate topped out at 18.61% in Q3 2025 and bottomed at 81.12% in Q4 2025.
  • Average Tax Rate over 3 years is 8.55%, with a median of 2.83% recorded in 2022.
  • Peak annual rise in Tax Rate hit 2473bps in 2025, while the deepest fall reached -7686bps in 2025.
  • Oramed Pharmaceuticals' Tax Rate stood at 1.4% in 2022, then plummeted by -204bps to 4.25% in 2024, then crashed by -1808bps to 81.12% in 2025.
  • Per Business Quant, the three most recent readings for ORMP's Tax Rate are 81.12% (Q4 2025), 18.61% (Q3 2025), and 0.96% (Q2 2025).